Advertisement

Topics

Intersect ENT Submits New Drug Application to FDA for Office-Based RESOLVE Steroid Releasing Implant for Recurrent Chronic Sinus Disease

08:00 EST 8 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Submission Supported by Four Clinical Studies Evaluating Safety and Effectiveness Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, tod...

Other Sources for this Article

Intersect ENT, Inc.
Investors:
Jeri Hilleman, 650-641-2105
ir@intersectENT.com
or
Media:
Nicole Osmer, 650-454-0504
nicole@nicoleosmer.com

NEXT ARTICLE

More From BioPortfolio on "Intersect ENT Submits New Drug Application to FDA for Office-Based RESOLVE Steroid Releasing Implant for Recurrent Chronic Sinus Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...